SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible
Securities Fraud Violations by the Board of Directors of United Therapeutics Corporation -- UTHR
Levi & Korsinsky announces it has commenced an investigation of United Therapeutics Corporation (“United Therapeutics” or
the “Company”) (NASDAQ: UTHR) concerning possible violations of federal securities laws.
On July 27, 2017, United Therapeutics disclosed that it has set aside $210 million in connection to a possible settlement with
the U.S. Department of Justice whether the company’s contributions to patient-assistance charity groups violate federal laws
against kickbacks and false claims. The DOJ previously subpoenaed United Therapeutics for information about its contributions to
non-profit organizations that provide financial assistance to patients with out-of-pocket drug costs. The company stated that it
expects any settlement would also include a corporate integrity agreement, and the company may incur significant future costs to
comply with that agreement. To obtain additional information, go to:
http://www.zlkdocs.com/UTHR-Info-Request-Form-5976
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar
outcomes.
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170728005397/en/